Dr Mark Salji

  • NES Clinical Lecturer (Institute of Cancer Sciences)

Publications

List by: Type | Date

Jump to: 2021 | 2020 | 2018 | 2017 | 2016
Number of items: 12.

2021

Ntala, C. et al. (2021) Analysis of prostate cancer tumor microenvironment identifies reduced stromal CD4 effector T-cell infiltration in tumors with pelvic nodal metastasis. European Urology Open Science, 29, pp. 19-29. (doi: 10.1016/j.euros.2021.05.001) (PMID:34337530) (PMCID:PMC8317840)

Cangiano, M. et al. (2021) Gene regulation network analysis on human prostate orthografts highlights a potential role for the JMJD6 regulon in clinical prostate cancer. Cancers, 13(9), 2094. (doi: 10.3390/cancers13092094) (PMID:33925994) (PMCID:PMC8123677)

2020

Blomme, A. et al. (2020) 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nature Communications, 11, 2508. (doi: 10.1038/s41467-020-16126-7) (PMID:32427840) (PMCID:PMC7237503)

Loveridge, C. J. et al. (2020) BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration. Oncogene, 39, pp. 1797-1806. (doi: 10.1038/s41388-019-1106-x) (PMID:31740786) (PMCID:PMC7033044)

2018

Salji, M. , Hendry, J., Patel, A., Ahmad, I. , Nixon, C. and Leung, H. Y. (2018) Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer. European Urology Focus, 4(6), pp. 858-866. (doi: 10.1016/j.euf.2017.01.019) (PMID:28753854) (PMCID:PMC6314965)

Bray, T. L., Salji, M. , Brombin, A., Pérez-López, A. M., Rubio-Ruiz, B., Galbraith, L. C.A., Patton, E. E., Leung, H. Y. and Unciti-Broceta, A. (2018) Bright insights into palladium-triggered local chemotherapy. Chemical Science, 9(37), pp. 7354-7361. (doi: 10.1039/c8sc02291g) (PMID:30542538) (PMCID:PMC6237126)

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi: 10.15252/emmm.201708347) (PMID:29540470) (PMCID:PMC5887544)

2017

Winchester, C. L., Salji, M. J. and Kasivisvanathan, V. (2017) Gathering preliminary data. Journal of Clinical Urology, 10(6), pp. 568-572. (doi: 10.1177/2051415817724713)

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi: 10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

2016

Salji, M. , Ahmad, I. and Winchester, C. (2016) Non-clinical research – laboratory based. Journal of Clinical Urology, 9(6), pp. 362-364. (doi: 10.1177/2051415816650134)

Winchester, C. and Salji, M. (2016) Writing a literature review. Journal of Clinical Urology, 9(5), pp. 308-312. (doi: 10.1177/2051415816650133)

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi: 10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

This list was generated on Fri Sep 17 06:55:07 2021 BST.
Jump to: Articles
Number of items: 12.

Articles

Ntala, C. et al. (2021) Analysis of prostate cancer tumor microenvironment identifies reduced stromal CD4 effector T-cell infiltration in tumors with pelvic nodal metastasis. European Urology Open Science, 29, pp. 19-29. (doi: 10.1016/j.euros.2021.05.001) (PMID:34337530) (PMCID:PMC8317840)

Cangiano, M. et al. (2021) Gene regulation network analysis on human prostate orthografts highlights a potential role for the JMJD6 regulon in clinical prostate cancer. Cancers, 13(9), 2094. (doi: 10.3390/cancers13092094) (PMID:33925994) (PMCID:PMC8123677)

Blomme, A. et al. (2020) 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nature Communications, 11, 2508. (doi: 10.1038/s41467-020-16126-7) (PMID:32427840) (PMCID:PMC7237503)

Loveridge, C. J. et al. (2020) BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration. Oncogene, 39, pp. 1797-1806. (doi: 10.1038/s41388-019-1106-x) (PMID:31740786) (PMCID:PMC7033044)

Salji, M. , Hendry, J., Patel, A., Ahmad, I. , Nixon, C. and Leung, H. Y. (2018) Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer. European Urology Focus, 4(6), pp. 858-866. (doi: 10.1016/j.euf.2017.01.019) (PMID:28753854) (PMCID:PMC6314965)

Bray, T. L., Salji, M. , Brombin, A., Pérez-López, A. M., Rubio-Ruiz, B., Galbraith, L. C.A., Patton, E. E., Leung, H. Y. and Unciti-Broceta, A. (2018) Bright insights into palladium-triggered local chemotherapy. Chemical Science, 9(37), pp. 7354-7361. (doi: 10.1039/c8sc02291g) (PMID:30542538) (PMCID:PMC6237126)

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi: 10.15252/emmm.201708347) (PMID:29540470) (PMCID:PMC5887544)

Winchester, C. L., Salji, M. J. and Kasivisvanathan, V. (2017) Gathering preliminary data. Journal of Clinical Urology, 10(6), pp. 568-572. (doi: 10.1177/2051415817724713)

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi: 10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

Salji, M. , Ahmad, I. and Winchester, C. (2016) Non-clinical research – laboratory based. Journal of Clinical Urology, 9(6), pp. 362-364. (doi: 10.1177/2051415816650134)

Winchester, C. and Salji, M. (2016) Writing a literature review. Journal of Clinical Urology, 9(5), pp. 308-312. (doi: 10.1177/2051415816650133)

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi: 10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

This list was generated on Fri Sep 17 06:55:07 2021 BST.